Long-term cerebral effects of CNS chemotherapy in children with acute lymphoblastic leukemia

Pediatr Hematol Oncol. 1993 Jul-Sep;10(3):267-70. doi: 10.3109/08880019309029495.

Abstract

Fifteen 7-16-year-old patients, treated in 1981-1984 for acute lymphoblastic leukemia (ALL) in first complete remission, were studied. As a central nervous system prophylaxis, all the children were treated with repeated methotrexate (MTX) instillations, but none were irradiated. The study protocol included magnetic resonance (MR) and a battery of neuropsychological tests. Small, punctate white-matter lesions were found by MR in eight children, probably minor vascular lesions. All the children were within normal intelligence range with a mean total WISC-R IQ of 109. Minor neuropsychologic problems were found in two patients, while one child showed a more extensive specific learning disorder in school.

MeSH terms

  • Adolescent
  • Atrophy
  • Brain / pathology
  • Brain Diseases / chemically induced*
  • Brain Diseases / diagnostic imaging
  • Brain Diseases / pathology
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • Humans
  • Infusions, Intravenous
  • Injections, Spinal / adverse effects
  • Learning Disabilities / chemically induced
  • Learning Disabilities / complications
  • Magnetic Resonance Imaging
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Neuropsychological Tests
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Survival Rate
  • Survivors / psychology
  • Tomography, X-Ray Computed

Substances

  • Methotrexate